ArticleHealthcare (Basel, Switzerland)2023
Developing an AI-Assisted Educational Chatbot for Radiotherapy Using the IBM Watson Assistant Platform.
Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.
- Digital affordances of AI chatbots in nursing education: a systematic review of learning gains and gaps in the evidence.Frontiers in medicine · 2026Pooled it
- Pooled it
- AI-assisted PEG aftercare education for older adults: clinician-informed chatbot design (PEGAssist).European geriatric medicine · 2026Article
- Development of an AI-driven chatbot for medication-assisted treatment standards in Scotland.Frontiers in digital health · 2026Article
- A Review on Biomarker-Enhanced Machine Learning for Early Diagnosis and Outcome Prediction in Ovarian Cancer Management.Cancer medicine · 2025Review
- Large language model integrations in cancer decision-making: a systematic review and meta-analysis.NPJ digital medicine · 2025Article
- Industrial applications of large language models.Scientific reports · 2025Article
- Assessing the Quality and Reliability of ChatGPT's Responses to Radiotherapy-Related Patient Queries: Comparative Study With GPT-3.5 and GPT-4.JMIR cancer · 2025Article
- Allies not enemies-creating a more empathetic and uplifting patient experience through technology and art.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025Review
- Developing Effective Frameworks for Large Language Model-Based Medical Chatbots: Insights From Radiotherapy Education With ChatGPT.JMIR cancer · 2025Article
- Usefulness and Ease of Use of an Artificial Intelligence Chatbot for Kidney Stone Formers.Cureus · 2025Article
- Generative AI's healthcare professional role creep: a cross-sectional evaluation of publicly accessible, customised health-related GPTs.Frontiers in public health · 2025Observational
- Ethical Considerations in Human-Centered AI: Advancing Oncology Chatbots Through Large Language Models.JMIR bioinformatics and biotechnology · 2024Article
- Assessing Generative Pretrained Transformers (GPT) in Clinical Decision-Making: Comparative Analysis of GPT-3.5 and GPT-4.Journal of medical Internet research · 2024Article
- The Potential of ChatGPT for High-Quality Information in Patient Education for Sports Surgery.Cureus · 2024Article
- Ethical Concerns About ChatGPT in Healthcare: A Useful Tool or the Tombstone of Original and Reflective Thinking?Cureus · 2024Review
- The Potential Applications and Challenges of ChatGPT in the Medical Field.International journal of general medicine · 2024Review
- TinyML-Based Lightweight AI Healthcare Mobile Chatbot Deployment.Journal of multidisciplinary healthcare · 2024Article
- Assessment of the Reliability and Clinical Applicability of ChatGPT's Responses to Patients' Common Queries About Rosacea.Patient preference and adherence · 2024Article
- Can the Use of Artificial Intelligence-Generated Content Bridge the Cancer Knowledge Gap? A Longitudinal Study With Health Self-Efficacy as a Mediator and Educational Level as a Moderator.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.